EMA – Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics – 24 September 2024: event’s materials are now available

The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) organised a multi-stakeholder hybrid workshop on Pharmacogenomics at EMA in Amsterdam.

The objectives of the workshop were to:

• identify priority areas for additional regulatory action to promote the clinical implementation of pharmacogenomics;
• discuss how medicines regulators can facilitate the uptake of genomics by national healthcare systems;
• discuss how to leverage genomic data linked to real-world data sources with examples of current studies using such data;
• discuss how to increase the regulatory impact of EU-funded projects in personalised medicine.

Find the presentations and the video recording of the event on the EMA Website.